193 related articles for article (PubMed ID: 30409300)
1. Adaptive radiotherapy for head and neck cancer: Are we ready to put it into routine clinical practice?
Gensheimer MF; Le QT
Oral Oncol; 2018 Nov; 86():19-24. PubMed ID: 30409300
[TBL] [Abstract][Full Text] [Related]
2.
Qiu J; Lv B; Fu M; Wang X; Zheng X; Zhuo W
Head Neck; 2017 Dec; 39(12):2519-2527. PubMed ID: 28963789
[TBL] [Abstract][Full Text] [Related]
3. Head and Neck Cancers: Advantages of Advanced Radiation Therapy and Importance of Supportive Care.
Spencer S
J Natl Compr Canc Netw; 2018 May; 16(5S):666-669. PubMed ID: 29784752
[TBL] [Abstract][Full Text] [Related]
4. PET/CT-guided dose-painting versus CT-based intensity modulated radiation therapy in locoregional advanced nasopharyngeal carcinoma.
Liu F; Xi XP; Wang H; Han YQ; Xiao F; Hu Y; He Q; Zhang L; Xiao Q; Liu L; Luo L; Li Y; Mo Y; Ma HZ
Radiat Oncol; 2017 Jan; 12(1):15. PubMed ID: 28587681
[TBL] [Abstract][Full Text] [Related]
5. Adaptive radiotherapy in head and neck cancer is required to avoid tumor underdose.
Castelli J; Simon A; Rigaud B; Chajon E; Thariat J; Benezery K; Vauleon E; Jegoux F; Henry O; Lafond C; de Crevoisier R
Acta Oncol; 2018 Sep; 57(9):1267-1270. PubMed ID: 29706107
[No Abstract] [Full Text] [Related]
6. Developing an adaptive radiation therapy strategy for nasopharyngeal carcinoma.
Fung WW; Wu VW; Teo PM
J Radiat Res; 2014 Mar; 55(2):293-304. PubMed ID: 23988444
[TBL] [Abstract][Full Text] [Related]
7. Radiation-induced nasopharyngeal ulcers after intensity modulated radiotherapy in primary nasopharyngeal carcinoma patients: A dose-volume-outcome analysis.
Li Y; Xu T; Qian W; Lu X; Hu C
Oral Oncol; 2018 Sep; 84():1-6. PubMed ID: 30115466
[TBL] [Abstract][Full Text] [Related]
8. Will weight loss cause significant dosimetric changes of target volumes and organs at risk in nasopharyngeal carcinoma treated with intensity-modulated radiation therapy?
Chen C; Fei Z; Chen L; Bai P; Lin X; Pan J
Med Dosim; 2014; 39(1):34-7. PubMed ID: 24140235
[TBL] [Abstract][Full Text] [Related]
9. DAHANCA 33: functional image-guided dose-escalated radiotherapy to patients with hypoxic squamous cell carcinoma of the head and neck (NCT02976051).
Saksø M; Primdahl H; Johansen J; Nowicka-Matus K; Overgaard J;
Acta Oncol; 2020 Feb; 59(2):208-211. PubMed ID: 31805799
[No Abstract] [Full Text] [Related]
10. [Proton therapy for head and neck squamous cell carcinomas: From physics to clinic].
Beddok A; Vela A; Calugaru V; Tessonnier T; Kubes J; Dutheil P; Gérard A; Vidal M; Goudjil F; Florescu C; Kammerer E; Bénézery K; Hérault J; Bourhis J; Thariat J;
Cancer Radiother; 2019 Sep; 23(5):439-448. PubMed ID: 31358445
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric Evaluation of Incorporating Patient Geometric Variations Into Adaptive Plan Optimization Through Probabilistic Treatment Planning in Head and Neck Cancers.
Liu Q; Liang J; Zhou D; Krauss DJ; Chen PY; Yan D
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):985-997. PubMed ID: 29976511
[TBL] [Abstract][Full Text] [Related]
12. Complete response to radiation therapy for nasopharyngeal sarcomatoid carcinoma.
Lee MJ; Son HJ
J Cancer Res Ther; 2020; 16(3):653-656. PubMed ID: 32719284
[TBL] [Abstract][Full Text] [Related]
13. Salvage treatment using carbon ion radiation in patients with locoregionally recurrent nasopharyngeal carcinoma: Initial results.
Hu J; Bao C; Gao J; Guan X; Hu W; Yang J; Hu C; Kong L; Lu JJ
Cancer; 2018 Jun; 124(11):2427-2437. PubMed ID: 29579324
[TBL] [Abstract][Full Text] [Related]
14. Target delineation and dose prescription of adaptive replanning intensity-modulated radiotherapy for nasopharyngeal carcinoma.
Xie D; Cheng W; Lv S; Zhong R; Wang L; Hu J; Wang M; Huang S; Su Y; Xia Y
Cancer Commun (Lond); 2019 Apr; 39(1):18. PubMed ID: 30987678
[No Abstract] [Full Text] [Related]
15. [Adaptive radiotherapy for nasopharyngeal carcinomas: Where are we?].
Hend D; Mnejja W; Fourati N; Kallel M; Siala W; Sahnoun T; Farhat L; Daoud J
Bull Cancer; 2020 May; 107(5):565-573. PubMed ID: 32245602
[TBL] [Abstract][Full Text] [Related]
16. A feasibility study on adaptive
Schatteman J; Van Gestel D; Berwouts D; De Gersem W; De Kerf G; De Neve W; De Ost B; Olteanu AML; Rottey S; Vercauteren T; Goethals I; Duprez F
Strahlenther Onkol; 2018 Aug; 194(8):727-736. PubMed ID: 29556677
[TBL] [Abstract][Full Text] [Related]
17. Radiation-induced optic neuropathy after stereotactic and image guided intensity-modulated radiation therapy (IMRT).
Brecht S; Boda-Heggemann J; Budjan J; Siebenlist K; Stieler F; Steil V; Wenz F; Lohr F; Buergy D
Radiother Oncol; 2019 May; 134():166-177. PubMed ID: 31005211
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of a Skin Dose Reduction for Nasopharyngeal Carcinoma Treated With High-Intensity-Modulated Delivery Techniques.
Liao X; Li J; Wang P; Yao X; Zhang Y; Tan T; Orlandini LC
Technol Cancer Res Treat; 2018 Jan; 17():1533033818803582. PubMed ID: 30343642
[TBL] [Abstract][Full Text] [Related]
19. Replanning during intensity modulated radiation therapy improved quality of life in patients with nasopharyngeal carcinoma.
Yang H; Hu W; Wang W; Chen P; Ding W; Luo W
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):e47-54. PubMed ID: 23122981
[TBL] [Abstract][Full Text] [Related]
20. A broadly adaptive array of dose-constraint templates for planning of intensity-modulated radiation therapy for advanced T-stage nasopharyngeal carcinoma.
Chau RM; Leung SF; Kam MK; Cheung KY; Kwan WH; Yu KH; Chiu KW; Cheung ML; Chan AT
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):21-8. PubMed ID: 19171440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
